Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Blogs

The stem cell the With over 280 therapies under evaluation * Roots Analysis *

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.   Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical T

‘‘Microbial Contract Biomanufacturing Market, 2020-2030’’ *Roots Analysis*

To order this detailed 320+ page report, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html   Key Inclusions §  A detailed review of the current landscape of companies offering contract manufacturing services for biologics, using microbial expression systems, along with information on their year of establishment, company size, location of headquarters, number and location of their production facilities, scale of operation (pre

Manufacturing and support services, for various types of biologics that are manufactured *Roots Analysis*

Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue rely

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030 *Roots Analysis*

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs   Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030.   The report features an extensive study of the current market landscape and future opportunities

Microbial contract biomanufacturing market is, growing at a CAGR of 8.7%, *Roots Analysis*

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment     London   Roots Analysis has announced the addition of the “Microbial Contract Biomanufacturing Market, 2020-2030” report to its list of offerings.   Despite mammalian cell cultures being the preferred manufactur

“Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” *Roots Analysis*

To order this detailed 370+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html   Key Inclusions §  A detailed review of the overall landscape of bispecific antibody therapeutics, including information on drug developers, phase of development (marketed, clinical, and preclinical / discovery) of the pipeline candidates, target antigen, type of antibody format, mechanism of action, target disease indication(s), therapeu

With two approved drugs and close to 300 clinical / preclinical product candidates *Roots Analysis*

With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.   To order this 370+ page report, which features 90+ figures and 110+ tables, please v

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%

Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 370+ page report, which features 90+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html   Key Market Insights          §  With two approved drugs and close to 300 clin

Bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community   Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.”   The report features an extensive study of the current market landscape, offeri

“Antibody Contract Manufacturing Market, 2020-2030” *Roots Analysis*

To order this detailed 285+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html   Key Inclusions §  A detailed review of the overall landscape of companies, offering contract services for the manufacturing of antibodies, along with information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of headquarters, number of manufacturing facilities and location of th

Several companies worldwide claim to possess the required expertise *Roots Analysis*

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to cont

The antibody contract manufacturing market is estimated to be worth USD 17 billion in 2030, predicts Roots Analysis

The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well   Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.   The report features an extensive study of the current market lands

Antibody contract manufacturing market is growing at an annualized rate of 12%, *Roots Analysis *

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone   Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.   Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating

“Global Handheld Ultrasound Imaging Devices Market, 2020-2030” <Roots Analysis>

To order this detailed 235+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html   Key Inclusions §  An overview of the current market landscape of the handheld ultrasound imaging devices, providing information on the status of development, application area (abdomen, cardiac, gynecological, pulmonary, urological scanning and others), weight of device, type of transducer array (convex / curved, linear, micro-convex,

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).   To order this 235+ page report, which features 9

The global handheld ultrasound imaging devices market growing at a CAGR of 11%, <Roots Analysis>

Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices; handheld ultrasound scanners have emerged as a novel solution to cater to the unmet need in this domain. In fact, the demand for handheld ultrasound devices is on a surge amidst the COVID-19 pandemic. These portable, pocket-friendly, point-of-care devices have revolutionized the treatment of COVID-19 patients by provide remote access to doctors and ensures

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030.

The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes   Roots Analysis has announced the addition of “Global Handheld Ultrasound Imaging Devices Market, 2020-2030” report to its list of offerings.   According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by

“Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” <Roots Analysis>

To order this 750+ page report, please visit this - https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html   Key Inclusions §  A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters, such as scale of operation (preclinical, clinical and c

Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug~

Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth emphasizing that, since 2000, more than 115 new CMOs have been established in order to serve to the growing demand for novel biologics that have specific manufacturing requirements. The contemporary contract services market features a mix of large and small-sized CMOs and is characterized by multiple mergers and acquisitions a

Biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~8%, *till 2030*

Roots Analysis has done a detailed study on Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 750+ page report, which features 200+ figures and 250+ tables, please visit this - https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html   Key Market Insights §  Over 235 companie

Biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030, Roots Analysis

Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages   Roots Analysis is pleased to announce the publication of its recent study, titled,  “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030.”    The report features an extensive study on the contract service providers within the biopharmaceutical i

“Virtual Clinical Trial Service Providers Market, 2020-2050” *Roots Analysis*

To order this 280+ page report, please visit this - https://www.rootsanalysis.com/reports/virtual-clinical-trial-service-provides-market.html   Key Inclusions §  An overview of the current market landscape of companies offering solutions for virtual clinical trials, featuring information on year of establishment, geographical location, company size and types of services offered (study start-up, patient enrollment, drug logistics, data collection and analysis, and patient retention

Currently, many companies claim to have advanced technology platforms, optimizing associated costs and the total time spent on conducting trials

Owing to its patient-centric approach, virtual / decentralized clinical trials are believed to potentially transform the conventional clinical research process. Virtual clinical trials implement innovative and advanced technological solutions, such as telemedicine and remote monitoring to minimize delays associated with the overall drug development process. The increased adoption of digital solutions by the healthcare industry and the cost saving potential of virtual clinical trials are likely t
×
  • Create New...